Evidence map›Paper›PMID 32388619›Full record

ArticlePsychopharmacology2020

Neurochemical and behavioral comparisons of contingent and non-contingent methamphetamine exposure following binge or yoked long-access self-administration paradigms.

Catherine A Schweppe, Caitlin Burzynski, Subramaniam Jayanthi, Bruce Ladenheim, Jean Lud Cadet, Eliot L Gardner, Zheng-Xiong Xi, Henriette van Praag, Amy Hauck Newman, Thomas M Keck

Open access · greenAbstract readComparative Study
In one paragraph

Article in Psychopharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Bidirectional causality between addiction and cognitive deficits.International review of neurobiology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Catherine A SchweppeMolecular Targets and Medications Discovery Branch, National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health, Baltimore, 333 Cassell Drive, Baltimore, MD, 21224, USA.
Caitlin BurzynskiMolecular Targets and Medications Discovery Branch, National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health, Baltimore, 333 Cassell Drive, Baltimore, MD, 21224, USA.
Subramaniam JayanthiMolecular Neuropsychiatry Research Branch, National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health, Baltimore, 333 Cassell Drive, Baltimore, MD, 21224, USA.
Bruce LadenheimMolecular Neuropsychiatry Research Branch, National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health, Baltimore, 333 Cassell Drive, Baltimore, MD, 21224, USA.
Jean Lud CadetMolecular Neuropsychiatry Research Branch, National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health, Baltimore, 333 Cassell Drive, Baltimore, MD, 21224, USA.
Eliot L GardnerMolecular Targets and Medications Discovery Branch, National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health, Baltimore, 333 Cassell Drive, Baltimore, MD, 21224, USA.
Zheng-Xiong XiMolecular Targets and Medications Discovery Branch, National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health, Baltimore, 333 Cassell Drive, Baltimore, MD, 21224, USA.
Henriette van PraagNeuroplasticity and Behavior Unit, Laboratory of Neurosciences, National Institute on Aging - Intramural Research Program, National Institutes of Health, Baltimore, MD, 21224, USA.
Amy Hauck NewmanMolecular Targets and Medications Discovery Branch, National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health, Baltimore, 333 Cassell Drive, Baltimore, MD, 21224, USA.
Thomas M KeckMolecular Targets and Medications Discovery Branch, National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health, Baltimore, 333 Cassell Drive, Baltimore, MD, 21224, USA. keckt@rowan.edu.
National Institute on Drug Abuse · USNational Institutes of Health · USFlorida Atlantic University · USRowan University · US

Funding

Novel Dopamine D3 Receptor Ligands ZIADA000424 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI NEWMAN, AMY HAUCK · 2009 to 2025
$25.9M
Basic brain mechanisms underlying drug addiction, craving, and relapseZIADA000478 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI GARDNER, ELIOT · 2009 to 2023
$7.9M
NOVEL DOPAMINE D3 RECEPTOR LIGANDSZ01DA000424 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI NEWMAN, AMY HAUCK · 1999 to 2008
$1.8M
Intramural NIH HHS Z01 DA000424Intramural NIH HHS ZIA DA000424
6 · The paper itself

Abstract

rationaleAbuse of the psychostimulant methamphetamine (METH) can cause long-lasting damage to brain monoaminergic systems and is associated with profound mental health problems for users, including lasting cognitive impairments. Animal models of METH exposure have been useful in dissecting the molecular effects of the drug on cognition, but many studies use acute, non-contingent "binge" administrations of METH which do not adequately approximate human METH use. Long-term METH exposure via long-access (LgA) self-administration paradigms has been proposed to more closely reflect human use and induce cognitive impairments.

objectiveTo better understand the role of contingency and patterns of exposure in METH-induced cognitive impairments, we analyzed behavioral and neurochemical outcomes in adult male rats, comparing non-contingent "binge" METH administration with contingent (LgA) METH self-administration and non-contingent yoked partners.

resultsBinge METH (40 mg/kg, i.p., over 1 day) dramatically altered striatal and hippocampal dopamine, DOPAC, 5-HT, 5-HIAA, BDNF, and TrkB 75 days after drug exposure. In contrast, 6-h LgA METH self-administration (cumulative 24.8-48.9 mg METH, i.v., over 16 days) altered hippocampal BDNF in both contingent and yoked animals but reduced striatal 5-HIAA in only contingent animals. Neurochemical alterations following binge METH administration were not accompanied by cognitive deficits in Morris water maze, novel object recognition, or Y-maze tests. However, contingent LgA METH self-administration resulted in impaired spatial memory in the water maze.

conclusionsOverall, substantial differences in neurochemical markers between METH exposure and self-administration paradigms did not consistently translate to deficits in cognitive tasks, highlighting the complexity of correlating METH-induced neurochemical changes with cognitive outcomes.

Indexed as

3,4-Dihydroxyphenylacetic AcidAnimalsCentral Nervous System StimulantsCognitionDopamineDopamine Plasma Membrane Transport ProteinsHippocampusHydroxyindoleacetic AcidMaleMaze LearningMemory DisordersMethamphetamineRatsRats, WistarSelf Administration3,4-Dihydroxyphenylacetic AcidCentral Nervous System StimulantsDopamineDopamine Plasma Membrane Transport ProteinsHydroxyindoleacetic AcidMethamphetamineCognitive performanceMethamphetamineNeurotoxicitySelf-administrationSpatial working memory

Identifiers

PMID32388619
PMCPMC7974824
OpenAlexW3022853982

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.